Ayurvedic products firm Zandu Pharmaceutical Works (Zandu) zoomed 19.54 per cent to close at Rs 9,714.90 after Emami raised its stake in the company to 27.51 per cent for an undisclosed amount.

<tr><td><p class='TableClas'></p><P class='TableClas'> <DIV CLASS=rightDiv><script language="JavaScript">
		google_ad_client = 'businessstandard';
		//google_ad_client = 'ca-businessstandard_js';
		google_ad_width = 200;
		google_ad_height = 200;
		google_ad_format = "200x200_as";
		google_ad_type = "text";
		google_ad_channel = "";
		//google_color_border = "FFFFFF";
		google_color_border = "F7F7F7";
		//google_color_bg = "FFFFFF";
		google_color_bg = "ffffff";
		//google_color_link = "639ACE";
		google_color_link = "0253B7";
		google_color_text = "000000";
		google_color_url = "D63431";
		//google_skip = adsenseSkip;
		</script> 
		<script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
		</script> </DIV><p class='TableClas'>Emami will make an open offer to all the remaining equity shareholders of Zandu for acquiring 20 per cent equity at Rs 7,315 a share. 
</p><p class='TableClas'>The stock made a new 52 week high at Rs 9,752.60, which was the 20 per cent upper circuit limit. The intraday low for the stock was Rs 8,400. The stock has gained about 42 per cent in the last one week. </P></p></table>


Zandu Pharmaceutical in fine fettle on stake increase

DALAL STREET SPIKES

More From This Section

Idea shares fall after Q3 earnings disappoint

BofA-Merrill raises Indiabulls to 'buy', stock gains

Suzlon stocks jump 17% on CDR approval

Maruti Suzuki rallies as Q3 profit beats analyst's estimates

Explore News